Please note we have changed our decision process and now have application deadlines. See below for further details.
- The principal investigator will be a senior researcher working in an established research institution in the UK.
The project should not normally exceed £250,000. This is to support the early stage development of new cardiovascular medicines and technologies so that they are attractive for follow-on funding.
- The development can be for therapeutics (novel / repurposed), devices, imaging technologies, diagnostics, computer models and algorithms.
- Your project should be novel, inventive and address an unmet clinical need.
- Your project should include:
- Robust target validation data
- Milestones with clear no/no go decisions
- A strategy to navigate the regulatory process
- A commercialisation plan
- An understanding of the Intellectual Property (IP) landscape
The BHF and your institution's Technology Transfer Office (TTO) are able to provide advice on your project plan. A project with potential can be developed between the preliminary outline and full application with guidance from our Translational Awards Committee.
If you are unsure whether your research is at the appropriate stage or is eligible for funding, please contact a member of the team at [email protected].
Award may include
The award can be used flexibly to advance the medicine or technology in the most effective manner. For example, it can be used for staff salaries (excluding PhD studentships), consumables and essential research equipment, IP consultancy fees and outsourcing to contract research organisations.
Longer term project goals
In your application, it is important to consider the entire route to commercialisation for your technology and not just what will be funded by this particular Translational Award.
Providing this information gives the BHF and subsequent investors the confidence that the project is well designed and has the best chance of success.
The MHRA Innovation Office provides a free, informal service that can help with your regulatory queries.
Hear from the experts
We held a workshop, ‘How to Translate your Research’, earlier this year. Committee members and industry experts discussed what they look for in a good project.
How to apply
Applications are assessed in a two-stage process:
Preliminary outline applications
The first step involves review of an outline application by the Translational Awards Committee (meets twice a year). The Committee will provide advice about the suitability of your project for the award.
Please complete the Outline Application Form referring to Translational Award Outline Application Guidelines and Translational Award Terms & Conditions. Applications must be completed in partnership with your institution's TTO.
Successful outline applicants will be asked to complete a full application form. Your full application will be reviewed by external peer review and by the Translational Awards Committee. Full applications will be reviewed in detail on scientific merit and on commercial viability.
Specific guidance for preparation of full applications will be provided along with outline application feedback. If your proposal includes animal work or human tissue, please complete a questionnaire on experiments on animals form (EXA) or a questionnaire on experiments involving human subjects form (EXH) as necessary.
We have changed our process from an open round to two application rounds a year and the deadline dates are below. Applications must be received by midday. Late submissions will not be considered.
Outline and full applications will be reviewed at Committee meetings. If your outline application is approved; you are invited to submit a full application, which will be assessed at the next meeting.
October 2016 round
- Preliminary outline application deadline – 20th October 2016
- Full application deadline - 8th March 2017
April 2017 round
- Preliminary outline application deadline - 24th April 2017
- Full application deadline – 6th September 2017
We will acknowledge receipt of your application within 1 working week and we will advise when you can expect the result. BHF reserve the right to change the deadline dates and we recommend that you check this page on a regular basis to take note of any changes.
Please allow 7 months from submission to decision.
Project management and reporting
Successful Translational Awards require efficient management and reporting to ensure that the project stays on target and to indicate whether a milestone has been met satisfactorily. A project manager may be appointed by the BHF to assist with this.